COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY AND BENDAMUSTIN

• 收藏
• 分享

专利权人:

Roche Glycart AG

发明人:

HERTING, Frank,KLEIN, Christian

申请号：

DK10747168

公开号：

DK2464382T3

申请日:

2010.08.12

申请国别(地区):

DK

年份:

2017

代理人:

摘要：

The present invention is directed to the combination therapy of an afucosylated anti-CD20 antibody with bendamustine for the treatment of cancer, especially to the combination therapy of CD20 expressing cancers with an afucosylated humanized B-Ly1 antibody and bendamustine.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/